Roquette is a French, family-owned global producer of plant-based ingredients and pharmaceutical excipients. Founded in 1933 and headquartered in Lestrem, France, the company operates manufacturing and R&D sites across Europe, the Americas, and Asia, supplying the food and beverage, nutrition, pharmaceutical, personal care, paper and board, and industrial markets.
Its portfolio includes starches and starch derivatives from crops such as corn, wheat, potatoes, and peas; polyols (e.g., sorbitol, mannitol, maltitol); dietary fibers and sweetening solutions; and plant proteins, notably pea protein. In pharmaceuticals, Roquette supplies excipients for oral and parenteral dosage forms, including sugar alcohols, specialty starches, and cyclodextrins used for tableting, taste-masking, and solubility enhancement. The company applies biorefining and fermentation technologies to produce ingredients and bio-based intermediates, with an emphasis on renewable feedstocks and process efficiency.
chemXplore tracks 2 projects involving Roquette.
Roquette's role on them: Owner.
The acquisition will enhance Roquette's pharma product range, expand its US footprint, and boost its formulation and R&D capabilities, aiming to close by H1 2025 pending regulatory approval.
The plant will produce 10 kilotons/year of bio-based succinic acid, offering a renewable alternative to fossil feedstocks. It will use a yeast-based fermentation process, improving eco-footprint and efficiency.
